These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2561047)
1. Danazol and hepatic neoplasia: a case report. Middleton C; McCaughan GW; Painter DM; Stephen MS; Beale M; Fraser I Aust N Z J Med; 1989 Dec; 19(6):733-5. PubMed ID: 2561047 [TBL] [Abstract][Full Text] [Related]
5. Danazol-induced hepatocellular adenomas. A case report and review of the literature. Kahn H; Manzarbeitia C; Theise N; Schwartz M; Miller C; Thung SN Arch Pathol Lab Med; 1991 Oct; 115(10):1054-7. PubMed ID: 1654873 [TBL] [Abstract][Full Text] [Related]
6. Genital bleeding during the administration of danazol. Nakamura G; Yoshimitsu K; Imura M; Nakano H Asia Oceania J Obstet Gynaecol; 1988 Sep; 14(3):373-7. PubMed ID: 3178583 [No Abstract] [Full Text] [Related]
7. Persistent amenorrhea following discontinuation of danazol therapy. Peress MR Fertil Steril; 1984 Feb; 41(2):322-3. PubMed ID: 6698225 [No Abstract] [Full Text] [Related]
8. Female pseudohermaphroditism associated with danazol exposure in utero. Case report. Shaw RW; Farquhar JW Br J Obstet Gynaecol; 1984 Apr; 91(4):386-9. PubMed ID: 6712899 [No Abstract] [Full Text] [Related]
9. Pseudohypertestosteronemia during danazol therapy. A case report. Miller EJ; Coleman FH J Reprod Med; 1990 Jun; 35(6):661-2. PubMed ID: 2359064 [TBL] [Abstract][Full Text] [Related]